PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that its PCT patent application covering a targeted therapy to treat solid cancerous tumors was published on September 27, 2018
October 9, 2018
· 5 min read